005500Samjin Pharmaceuticals005500 info
$13.67info-0.38%24h
Global rank18167
Market cap$174.69M
Change 7d-0.33%
YTD Performance-16.21%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Samjin Pharmaceuticals (005500) Stock Overview

    Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as medicine for treatment of chronic diseases. It also develops SA001, which is in Phase II clinical trial for the treatment for dry eye syndrome and Sjogren syndrome; SJP1804 medicine that is Phase I clinical trial to treat macular degeneration; and SJP1604, which is in Phase I clinical trial for cancer; SJP1901 and SJP1902 for cancer treatment; SJP 1801 to treat Alzheimer's and Parkinson's disease; SJP006, an anti-viral product; and SJP003 for treatment of diabetes. In addition, the company's preclinical product is SJP1602 for the treatment of cancer. Samjin Pharmaceuticals Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.

    005500 Stock Information

    Symbol
    005500
    Address
    121 Wausan RoSeoul, 04054South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.samjinpharm.co.kr
    Country
    🇰🇷 South Korea
    Phone Number
    82 2 3140 0700

    Samjin Pharmaceuticals (005500) Price Chart

    -
    Value:-

    Samjin Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $13.67
    N/A
    Market Cap
    $174.69M
    N/A
    Shares Outstanding
    12.78M
    N/A
    Employees
    586.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org